- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 9.24M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.77M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.54M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.06M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.97M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $14.95M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $11.31M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $31.14M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $15.87M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $765.36K |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $265.79K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $10.59M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 9.22M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$520.79K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $743.57K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$492.31K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.01M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $61.64K |